Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function
- PMID: 9683390
- DOI: 10.1038/sj.ejcn.1600571
Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function
Abstract
Objective: This study describes the prevalence and characteristics of an elevated resting energy expenditure (REE) in patients with chronic obstructive pulmonary disease (COPD).
Design and setting: Patients were consecutively admitted to an in-patient pulmonary rehabilitation centre.
Subjects: The study group consisted of 172 (123 males) clinically stable patients with COPD, age mean (s.d.) 64(10) y).
Interventions: REE was assessed by indirect calorimetry (ventilated hood) and adjusted for the influence of fat-free mass (FFM; measured by bioelectrical impedance analysis) using the linear regression equations of REE on FFM generated in 92 healthy age-matched subjects (58 males, age 67(8) y) for men and women separately. The predicted REE adjusted for FFM (REEFFM) was obtained by using the FFM of each individual patient in the linear regression equation of REE on FFM generated in the healthy control group.
Results: 26% of the patients were hypermetabolic (defined as REE > 110% REEFFM), characterized by a lower age (60 (10) vs 65 (9) y) and a lower total lung capacity (TLC; 122(27)vs 139(28) %pred) compared to normometabolic patients (P < 0.001). The prevalence of FFM-depletion was equal among normo- and hypermetabolic patients: 36% vs 33% respectively. Depleted patients expressed however a significantly higher residual volume/TLC ratio and a lower maximal inspiratory mouth pressure independently of hypermetabolism (P < 0.05). In contrast, on base of the Harris & Benedict (HB) prediction equations, which do not take body composition into account, 54% of the patients were hypermetabolic (REE > 110% REEHB), characterized by a higher age and a lower body mass and FFM (P < 0.05).
Conclusions: Hypermetabolism commonly occurs in COPD, characterized by less hyperinflation at rest, in contrast to the suggested contribution of an elevated oxygen cost of breathing (OCB) to hypermetabolism in COPD. The higher hyperinflation at rest in FFM-depleted patients independently of hypermetabolism suggests a higher OCB during activities, contributing to the elevated total daily energy expenditure previously reported in COPD. The HB-equations overestimate the prevalence of hypermetabolism and link hypermetabolism incorrectly to aging and depletion.
Similar articles
-
Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD.Thorax. 1997 Sep;52(9):780-5. doi: 10.1136/thx.52.9.780. Thorax. 1997. PMID: 9371208 Free PMC article.
-
Resting energy expenditure in patients with chronic obstructive pulmonary disease.Am J Clin Nutr. 1991 Dec;54(6):983-7. doi: 10.1093/ajcn/54.6.983. Am J Clin Nutr. 1991. PMID: 1957831
-
Resting energy expenditure prediction using bioelectrical impedance analysis in patients with severe motor and intellectual disabilities.Brain Dev. 2019 Apr;41(4):352-358. doi: 10.1016/j.braindev.2018.11.003. Epub 2018 Nov 28. Brain Dev. 2019. PMID: 30501961
-
Indirect calorimetry and nutritional problems in clinical practice.Acta Diabetol. 2001;38(1):1-5. doi: 10.1007/s005920170022. Acta Diabetol. 2001. PMID: 11487171 Review.
-
The effects of chemotherapy on energy metabolic aspects in cancer patients: A systematic review.Clin Nutr. 2020 Jun;39(6):1863-1877. doi: 10.1016/j.clnu.2019.07.028. Epub 2019 Aug 7. Clin Nutr. 2020. PMID: 31420208
Cited by
-
Activity monitoring and energy expenditure in COPD patients: a validation study.COPD. 2007 Jun;4(2):107-12. doi: 10.1080/15412550701246658. COPD. 2007. PMID: 17530503 Free PMC article.
-
Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease.Metabolism. 2011 Oct;60(10):1449-55. doi: 10.1016/j.metabol.2011.02.013. Epub 2011 May 6. Metabolism. 2011. PMID: 21550084 Free PMC article. Clinical Trial.
-
Medical nutrition therapy in chronic obstructive pulmonary disease: A narrative review.Nutr Clin Pract. 2025 Aug;40(4):793-804. doi: 10.1002/ncp.11329. Epub 2025 Jun 11. Nutr Clin Pract. 2025. PMID: 40500248 Free PMC article. Review.
-
Energy efficient physiologic coupling of gait and respiration is altered in chronic obstructive pulmonary disease.Acta Physiol (Oxf). 2019 Apr;225(4):e13217. doi: 10.1111/apha.13217. Epub 2018 Dec 7. Acta Physiol (Oxf). 2019. PMID: 30414317 Free PMC article.
-
Comparison of the Results of Modeling Pulmonary Fibrosis in Sprague Dawley Rats by Intratracheal Administration of Bleomycin in the Form of Sulfate and Chloride at a Dose of 3 mg/kg.Pharmaceuticals (Basel). 2024 Oct 11;17(10):1360. doi: 10.3390/ph17101360. Pharmaceuticals (Basel). 2024. PMID: 39459000 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources